Connection
Robert McQueen to Multiple Sclerosis, Relapsing-Remitting
This is a "connection" page, showing publications Robert McQueen has written about Multiple Sclerosis, Relapsing-Remitting.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.920 |
|
|
|
-
McQueen RB, Nair KV, Vollmer TL, Campbell JD. Incorporating real-world clinical practice in multiple sclerosis economic evaluations. Expert Rev Pharmacoecon Outcomes Res. 2015; 15(6):869-72.
Score: 0.422
-
McQueen RB, Livingston T, Vollmer T, Corboy J, Buckley B, Allen RR, Nair K, Campbell JD. Increased relapse activity for multiple sclerosis natalizumab users who become nonpersistent: a retrospective study. J Manag Care Spec Pharm. 2015 Mar; 21(3):210-8b.
Score: 0.408
-
Campbell JD, McQueen RB, Miravalle A, Corboy JR, Vollmer TL, Nair K. Comparative effectiveness of early natalizumab treatment in JC virus-negative relapsing-remitting multiple sclerosis. Am J Manag Care. 2013 Apr; 19(4):278-85.
Score: 0.089